Xometry's (XMTR) "Sell (E+)" Rating Reaffirmed at Weiss Ratings

Key Points

• Xometry's stock received a "sell (E+)" rating from Weiss Ratings, which has been reaffirmed in a recent report.
• Several analysts have issued varying ratings and price targets for Xometry, with a consensus rating of "Hold" and an average target price of $41.22.
• The company's recent earnings report exceeded expectations, showing a revenue increase of 22.6% compared to the previous year, with earnings per share of $0.09.

Xometry (NASDAQ:XMTR - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by equities research analysts at Weiss Ratings in a report issued on Friday,Weiss Ratings reports.

Other equities analysts have also issued research reports about the company. UBS Group boosted their price objective on Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 6th. JMP Securities boosted their price objective on Xometry from $45.00 to $50.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Citigroup reissued an "outperform" rating on shares of Xometry in a research note on Friday, July 11th. The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $49.00 price target (up previously from $42.00) on shares of Xometry in a research note on Thursday, October 16th. Finally, Cantor Fitzgerald raised Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price target on the stock in a research note on Tuesday, August 5th. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $41.22.

Xometry Stock Performance

Shares of Xometry stock traded down $0.49 on Friday, reaching $49.76. 207,874 shares of the stock were exchanged, compared to its average volume of 716,178. The firm has a market capitalization of $2.53 billion, a price-to-earnings ratio of -40.45 and a beta of 0.89. Xometry has a twelve month low of $18.59 and a twelve month high of $58.03. The business has a 50 day moving average price of $50.34 and a two-hundred day moving average price of $38.23. The company has a quick ratio of 3.85, a current ratio of 3.91 and a debt-to-equity ratio of 1.20.

Xometry (NASDAQ:XMTR - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. The business had revenue of $162.55 million during the quarter, compared to analysts' expectations of $156.53 million. Xometry had a negative return on equity of 6.79% and a negative net margin of 10.20%.The business's revenue was up 22.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.01) earnings per share. Xometry has set its Q3 2025 guidance at EPS. Analysts anticipate that Xometry will post -0.66 earnings per share for the current fiscal year.

Insider Buying and Selling at Xometry

In related news, CFO James Miln sold 598 shares of the business's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $50.25, for a total value of $30,049.50. Following the sale, the chief financial officer owned 144,115 shares in the company, valued at approximately $7,241,778.75. The trade was a 0.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Randolph Altschuler sold 9,331 shares of the business's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $50.31, for a total value of $469,442.61. Following the completion of the sale, the chief executive officer owned 310,271 shares in the company, valued at $15,609,734.01. This represents a 2.92% decrease in their position. The disclosure for this sale can be found here. 9.66% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Xometry

Several large investors have recently bought and sold shares of XMTR. Gilder Gagnon Howe & Co. LLC increased its holdings in Xometry by 248.8% during the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 859,808 shares of the company's stock worth $29,053,000 after purchasing an additional 613,282 shares during the period. Nuveen LLC purchased a new stake in Xometry during the 1st quarter worth about $14,639,000. Next Century Growth Investors LLC increased its holdings in Xometry by 194.1% during the 1st quarter. Next Century Growth Investors LLC now owns 664,292 shares of the company's stock worth $16,554,000 after purchasing an additional 438,393 shares during the period. Stephens Investment Management Group LLC purchased a new stake in Xometry during the 2nd quarter worth about $13,292,000. Finally, First Trust Advisors LP increased its holdings in Xometry by 42.9% during the 2nd quarter. First Trust Advisors LP now owns 1,279,005 shares of the company's stock worth $43,218,000 after purchasing an additional 384,211 shares during the period. Hedge funds and other institutional investors own 97.31% of the company's stock.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.